{"id":"W2559226961","doi":"10.17925/eoh.2016.12.02.79","title":"Treatment Update for Women with Hormone Receptor-positive Advanced Breast Cancer","year":2016,"lang":"en","type":"article","venue":"European Oncology & Haematology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"AstraZeneca","keywords":"Anastrozole; Medicine; Fulvestrant; Breast cancer; Oncology; Internal medicine; Hormone receptor; Cancer; Hormonal therapy; Hormone therapy; Hormone; Gynecology; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001374605,0.0004227875,0.0008810234,0.0009993165,0.0004248607,0.001032428,0.000721436,0.002386965,0.008392286],"category_scores_gemma":[0.004096049,0.0002253605,0.000623898,0.001149845,0.0002121544,0.001130442,0.0004857465,0.002976129,0.003496487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000811927,"about_ca_system_score_gemma":0.001366374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001940806,"about_ca_topic_score_gemma":0.007255788,"domain_scores_codex":[0.9993766,0.0002088857,0.0001149003,0.00003395715,0.0002222154,0.00004357416],"domain_scores_gemma":[0.9975947,0.0008763653,0.0003504081,0.00004863742,0.0008759968,0.0002538323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002929178,0.0001082246,0.0008631091,0.002190168,0.00005952704,0.0003410827,0.00004926172,0.0001515118,0.0006387321,0.001125803,0.3775047,0.6166749],"study_design_scores_gemma":[0.00005863157,0.0001259811,0.001783872,0.001074916,0.00009055023,0.0007766385,0.00003994134,0.00007472278,0.0001128165,0.0004006368,0.9954526,0.000008637409],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003988598,0.747582,0.00237343,0.1670282,0.0242062,0.0001880663,0.001807719,0.0004761589,0.05234968],"genre_scores_gemma":[0.02739728,0.7910081,0.01185487,0.09517065,0.02742115,0.000495406,0.004583219,0.0001064306,0.04196285],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008392286,"threshold_uncertainty_score":0.02807498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004953099816584024,"score_gpt":0.2498291850781909,"score_spread":0.2448760852616069,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}